Literature DB >> 20931479

No prolonged effect of Ankaferd Blood Stopper on chronic radiation proctitis.

E Ozaslan1, T Purnak, G Ozyigit, F Akyol, A Yildiz, I C Haznedaroglu.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20931479     DOI: 10.1055/s-0030-1255773

Source DB:  PubMed          Journal:  Endoscopy        ISSN: 0013-726X            Impact factor:   10.093


× No keyword cloud information.
  6 in total

1.  Re: Kurt M, Onal I, Akdogan M, et al. Ankaferd Blood Stopper for controlling gastrointestinal bleeding due to distinct benign lesions refractory to conventional antihemorrhagic measures. Can J Gastroenterol 2010;24:380-4.

Authors:  Ersan Ozaslan
Journal:  Can J Gastroenterol       Date:  2010-10       Impact factor: 3.522

2.  Ankaferd hemostat in the management of gastrointestinal hemorrhages.

Authors:  Yavuz Beyazit; Murat Kekilli; Ibrahim C Haznedaroglu; Ertugrul Kayacetin; Metin Basaranoglu
Journal:  World J Gastroenterol       Date:  2011-09-21       Impact factor: 5.742

3.  Treatment of hemorrhagic gastritis by Ankaferd blood stopper versus Omeprazole: experimental randomized rat models.

Authors:  Hikmetullah Batgi; Erdem Akbal; Erdem Koçak; Ömer Akyürek; Seyfettin Köklü; Melahat Dönmez; Fahri Güneş
Journal:  Wien Klin Wochenschr       Date:  2015-04-10       Impact factor: 1.704

Review 4.  Role of hemostatic powders in the endoscopic management of gastrointestinal bleeding.

Authors:  Marco Bustamante-Balén; Gema Plumé
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

5.  Antibacterial Activities of Ankaferd Hemostat (ABS) on Shiga Toxin-Producing Escherichia coli and Other Pathogens Significant in Foodborne Diseases.

Authors:  Ahmet Koluman; Nejat Akar; İbrahim C Haznedaroğlu
Journal:  Turk J Haematol       Date:  2015-08-06       Impact factor: 1.831

6.  Oral high-dose ankaferd administration effects on gastrointestinal system.

Authors:  Erdem Akbal; Seyfettin Köklü; Hesna Müzeyyen Astarcı; Erdem Koçak; Gökhan Karaca; Yavuz Beyazıt; Güler Topcu; Bilgehan Acar; Dilek Ergün; İbrahim Celalettin Haznedaroğlu
Journal:  Int J Med Sci       Date:  2013-03-02       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.